Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Balance Labs (BLNC) Cash & Equivalents (2016 - 2025)

Balance Labs filings provide 12 years of Cash & Equivalents readings, the most recent being $4512.0 for Q3 2025.

  • On a quarterly basis, Cash & Equivalents changed N/A to $4512.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $4512.0, a N/A change, with the full-year FY2024 number at $13199.0, down 88.3% from a year prior.
  • Cash & Equivalents hit $4512.0 in Q3 2025 for Balance Labs, up from $3625.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $269740.0 in Q3 2022 to a low of $2000.0 in Q2 2021.
  • Median Cash & Equivalents over the past 5 years was $6079.0 (2021), compared with a mean of $78134.1.
  • Biggest five-year swings in Cash & Equivalents: soared 11277.9% in 2021 and later plummeted 99.26% in 2023.
  • Balance Labs' Cash & Equivalents stood at $227558.0 in 2021, then grew by 3.41% to $235311.0 in 2022, then tumbled by 52.06% to $112809.0 in 2023, then tumbled by 88.3% to $13199.0 in 2024, then crashed by 65.82% to $4512.0 in 2025.
  • The last three reported values for Cash & Equivalents were $4512.0 (Q3 2025), $3625.0 (Q2 2025), and $3040.0 (Q1 2025) per Business Quant data.